Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
N. Porta
Institution:
Institute of Cancer Research
Observed institution:
Institute of Cancer Research
ORCID:
0000-0003-2458-2167
Observed ORCID:
0000-0003-2458-2167
OpenAlex ID:
A5123689714
34O ATR inhibitor alone (ceralasertib) or in combination with olaparib in gynaecological cancers with ARID1A loss or no loss: Results from the ENGOT/GYN1/NCRI ATARI trial
2023
·
S. Banerjee
, A. Leary
, et al.
·
ESMO Open
·
26
PROspectiVe imaging research DEsign and coNducT (PROVIDENT): Considerations for clinical trials and studies using imaging (Part II)
2026
·
K. Biscombe
, N. Porta
, et al.
·
Radiography
·
5
PDF
PROspectiVe imaging research DEsign and coNducT (PROVIDENT): Considerations for clinical trials and studies using imaging (Part I)
2026
·
K. Biscombe
, N. Porta
, et al.
·
Radiography
·
2
PDF
Show more works
View as search
Works count:
3
Citation count:
33
H-index:
2
I10-index:
1
Year
Topic
Type